 | Fady Ibraham Malik Sells 2,000 Shares of Cytokinetics, Incorporated (NASDAQ:CYTK) Stock
americanbankingnews.com - October 14 at 8:22 PM |
 | How Much Upside is Left in Cytokinetics (CYTK)? Wall Street Analysts Think 37% - Nasdaq
nasdaq.com - October 11 at 3:03 PM |
 | How Much Upside is Left in Cytokinetics (CYTK)? Wall Street Analysts Think 37%
finance.yahoo.com - October 11 at 3:03 PM |
 | Where Cytokinetics Stands With Analysts - Benzinga - Benzinga
benzinga.com - October 8 at 4:22 PM |
| Cytokinetics (NASDAQ:CYTK) Stock Rating Reaffirmed by HC Wainwright
americanbankingnews.com - October 8 at 12:30 PM |
| Cytokinetics Outlines Go-To-Market Strategy for Omecamtiv Mecarbil and Provides Updates on Cardiovascular Pipeline at Today’s Analyst & Investor Day - Yahoo Finance
finance.yahoo.com - October 8 at 6:21 AM |
| Cytokinetics (NASDAQ:CYTK) Stock Price Up 8.1%
americanbankingnews.com - October 7 at 12:44 PM |
| Expert Ratings For Cytokinetics - Benzinga - Benzinga
benzinga.com - October 7 at 12:38 PM |
 | Cytokinetics (CYTK) Outlines Go-To-Market Strategy for Omecamtiv Mecarbil and Provides Updates on Cardiovascular Pipeline - StreetInsider.com
streetinsider.com - October 7 at 7:38 AM |
 | Cytokinetics Outlines Go-To-Market Strategy for Omecamtiv Mecarbil and Provides Updates on Cardiovascular Pipeline at - GlobeNewswire
globenewswire.com - October 7 at 7:38 AM |
|
| Cytokinetics Outlines Go-To-Market Strategy for Omecamtiv Mecarbil and Provides Updates on Cardiovascular Pipeline at Today’s Analyst & Investor Day
finance.yahoo.com - October 7 at 7:38 AM |
| Jefferies Financial Group Begins Coverage on Cytokinetics (NASDAQ:CYTK)
americanbankingnews.com - October 6 at 8:37 PM |
| Cytokinetics (NASDAQ:CYTK) Reaches New 52-Week High at $36.90
americanbankingnews.com - October 4 at 2:42 PM |
 | Circling Back On Cytokinetics - Seeking Alpha
seekingalpha.com - October 3 at 9:09 PM |
| Cytokinetics, Incorporated (NASDAQ:CYTK) Insider David Cragg Sells 7,569 Shares
americanbankingnews.com - October 1 at 5:26 PM |
| Cytokinetics (NASDAQ:CYTK) Trading Up 6%
americanbankingnews.com - September 30 at 12:58 PM |
 | Cramer's lightning round: Cytokinetics is a very good speculative play - CNBC
cnbc.com - September 28 at 7:54 PM |
| Cytokinetics Announces Fourth Annual Communications Fellowship Grant Program Call for Proposals - Yahoo Finance
finance.yahoo.com - September 28 at 2:52 PM |
| The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive - Benzinga
benzinga.com - September 28 at 9:51 AM |
| Cytokinetics Announces Fourth Annual Communications Fellowship Grant Program Call for Proposals - GlobeNewswire
globenewswire.com - September 28 at 9:51 AM |
| Cytokinetics Announces Fourth Annual Communications Fellowship Grant Program Call for Proposals
finance.yahoo.com - September 28 at 9:51 AM |
| Cytokinetics (NASDAQ:CYTK) Sets New 12-Month High at $35.47
americanbankingnews.com - September 27 at 12:58 PM |
| Cytokinetics to Host Analyst & Investor Day on October 7, 2021 - Yahoo Finance
finance.yahoo.com - September 25 at 6:47 PM |
| Cytokinetics to Host Analyst & Investor Day on October 7, 2021 - GlobeNewswire
globenewswire.com - September 23 at 6:30 PM |
| Cytokinetics to Host Analyst & Investor Day on October 7, 2021
finance.yahoo.com - September 23 at 6:30 PM |
| Cytokinetics (CYTK) Announces Results From REDWOOD-HCM and GALACTIC-HF Trials at the HFSA Annual Scientific Meeting - StreetInsider.com
streetinsider.com - September 13 at 6:47 AM |
| Cytokinetics Announces Results From REDWOOD-HCM and GALACTIC-HF Presented in Late Breaking Clinical Trial Session at the HFSA Annual Scientific Meeting
finance.yahoo.com - September 12 at 3:45 PM |
| Noteworthy Friday Option Activity: IIPR, TWTR, CYTK
nasdaq.com - September 12 at 9:48 AM |
| Cytokinetics to Participate in September Investor Conferences - Yahoo Finance
finance.yahoo.com - September 8 at 4:24 PM |
| Cytokinetics to Participate in September Investor Conferences
finance.yahoo.com - September 8 at 4:24 PM |
| Cytokinetics to Host Investor Call and Webcast to Discuss the Full Results From Redwood-HCM at the HFSA Annual Scientific Meeting - GlobeNewswire
globenewswire.com - September 7 at 12:51 PM |
| Cytokinetics to Host Investor Call and Webcast to Discuss the Full Results From Redwood-HCM at the HFSA Annual Scientific Meeting
finance.yahoo.com - September 7 at 12:51 PM |
|
| Cytokinetics Announces Results From REDWOOD-HCM and GALACTIC-HF to Be Presented in Late Breaking Clinical Trials Session at the HFSA Annual Scientific Meeting - Yahoo Finance
finance.yahoo.com - September 2 at 10:39 PM |
| Cytokinetics Announces Results From REDWOOD-HCM and - GlobeNewswire
globenewswire.com - August 31 at 11:00 AM |
| Noteworthy ETF Outflows: XBI, TBIO, EDIT, CYTK - Nasdaq
nasdaq.com - August 22 at 5:17 PM |
| Cytokinetics and Cure SMA Renew Partnership to Advance - GlobeNewswire
globenewswire.com - August 19 at 1:08 PM |
 | Cytokinetics CEO Robert Blum on Biopharma Outlook - Bloomberg
bloomberg.com - August 12 at 7:50 PM |
| Understanding Cytokinetics's Unusual Options Activity
benzinga.com - August 9 at 7:18 PM |
 | Cytokinetics, Incorporated (CYTK) Q2 2021 Earnings Call Transcript - Motley Fool
fool.com - August 6 at 12:39 PM |
| Cytokinetics, Incorporated (CYTK) Q2 2021 Earnings Call Transcript
finance.yahoo.com - August 6 at 12:39 PM |
| Cytokinetics Reports Second Quarter 2021 Financial Results - GlobeNewswire
globenewswire.com - August 6 at 7:38 AM |
| Cytokinetics, Incorporated (CYTK) CEO Robert Blum on Q2 2021 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - August 6 at 1:14 AM |
| Cytokinetics: Q2 Earnings Insights - Benzinga
benzinga.com - August 5 at 8:14 PM |
| Cytokinetics Reports Second Quarter 2021 Financial Results - Yahoo Finance
finance.yahoo.com - August 5 at 8:14 PM |
| Cytokinetics Reports Second Quarter 2021 Financial Results
finance.yahoo.com - August 5 at 8:14 PM |
| Cytokinetics (CYTK) Reports Q2 Loss, Misses Revenue Estimates
finance.yahoo.com - August 5 at 8:14 PM |
| Announcing: Cytokinetics (NASDAQ:CYTK) Stock Soared An Exciting 333% In The Last Three Years
nasdaq.com - August 4 at 8:20 AM |
 | Here's what to expect from Cytokinetics's earnings report - Markets Insider
markets.businessinsider.com - August 3 at 9:43 AM |
| Cytokinetics Announces Start of COURAGE-ALS, a Phase 3 Clinical Trial of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis - GlobeNewswire
globenewswire.com - August 2 at 7:51 AM |
| Cytokinetics Announces Start of COURAGE-ALS, a Phase 3 Clinical Trial of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis
finance.yahoo.com - August 2 at 7:51 AM |
